Adagio Medical Holdings earnings were -$27.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ADGM earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$6.7M, down 4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ADGM reported annual earnings of -$25.1M, with -53.3% growth. The next ADGM earnings date is Nov 11, 2026.
Adagio Medical Holdings Earnings Reports & History FAQ
What were Adagio Medical Holdings's earnings last quarter?
On ADGM's earnings call on Aug 12, 2026, Adagio Medical Holdings (NASDAQ: ADGM) reported Q2 2026 earnings per share (EPS) of -$0.30, up 15.38% year over year. Total ADGM earnings for the quarter were -$6.72 million. In the same quarter last year, Adagio Medical Holdings's earnings per share (EPS) was -$0.26.
When does Adagio Medical Holdings report earnings?
The next ADGM earnings date is Nov 11, 2026. Add ADGM to your watchlist to be reminded of Adagio Medical Holdings's next earnings date.
Is Adagio Medical Holdings profitable or losing money?
As of the last Adagio Medical Holdings earnings report, Adagio Medical Holdings is currently losing money. Adagio Medical Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$27.14 million, a 58.52% decrease year over year.
What was ADGM's earnings growth in the past year?
As of Adagio Medical Holdings's earnings date in Aug 12, 2026, Adagio Medical Holdings's earnings has grown year over year. ADGM earnings in the past year totalled -$27.14 million.
What are Adagio Medical Holdings's earnings expectations?
The current EPS estimate for Adagio Medical Holdings's earnings report in Nov 11, 2026 is -$0.30.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.